1. ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
   Rui Bi et al, 2019, Diagnostic Pathology CrossRef
2. Synchronous BRCA2 positive ovarian carcinoma with ALK positive NSCLC: Double trouble
   Ullas Batra et al, 2022, Human Pathology Reports CrossRef
3. Targeted siRNA nanotherapeutics against breast and ovarian metastatic cancer: a comprehensive review of the literature
   Abdus Subhan et al, 2022, Nanomedicine CrossRef
4. 18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases
   Paloma García-Talavera et al, 2019, Clinical Nuclear Medicine CrossRef
5. Female genital tract metastasis of lung adenocarcinoma with EGFR mutations: Report of two cases
   Run-Lan Yan et al, 2019, World Journal of Clinical Cases CrossRef
6. Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience
   Jing-Jing Zhang et al, 2020, Journal of Ovarian Research CrossRef
7. Ovarian Metastases from ALK-rearranged Lung Adenocarcinoma: A Case Report and Literature Review
   Hajime Sasano et al, 2018, Internal Medicine CrossRef
8. Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case report
   Shuyang Yao et al, 2021, BMC Women's Health CrossRef
9. Response to lorlatinib on a patient with ALK‐rearranged non‐small cell lung cancer harboring 1151Tins mutation with uterine metastasis
   Takashi Kobayashi et al, 2021, Thoracic Cancer CrossRef